COc1ccc(N2CCN(C(=O)c3ccc4c(=O)n(Cc5ccc6c(c5)OCO6)c(=O)[nH]c4c3)CC2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?